Search In this Thesis
   Search In this Thesis  
العنوان
Histopathological and Immunohistochemical Study of Colorectal Adenoma and ADenocarcinoma /
الناشر
Nisreen Dahi M. Toni,
المؤلف
Toni, Nisreen Dahi M.
هيئة الاعداد
باحث / Nisreen Dahi M. Toni
مشرف / Wafaa Farghaly Aref
مشرف / Ihab Talaat Saied
مشرف / Heba Mohamed Tawfik
الموضوع
Clinical Pathology . Colorectal - Adenoma .
تاريخ النشر
2006 .
عدد الصفحات
146 p.:
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
علم الأمراض والطب الشرعي
تاريخ الإجازة
1/1/2006
مكان الإجازة
جامعة المنيا - كلية الطب - BASIC MEDICAL SCIENCE (PATHOLOGY)
الفهرس
Only 14 pages are availabe for public view

from 157

from 157

Abstract

Colorectal cancer comprises 11% of all cancer incidence and 13% f all cancer mortality in the United States. However, the worldwide age icidence is rare before the age of 40 and then increases significantly in ach succeeding decade.
In Egypt the incidence of colorectal cancer is about 6.55% of the ill cancers represented to National Cancer Institutes and about 11.7% of he all cancers represented to his private practice. In Egypt, the mean jge of cancer patients is 48 years, two decades younger than the mean 3ge of American cancer patients.
Screening studies have indicated that CRC is typically diagnosed 10-15 years after adenoma detection.
Early detection of colorectal cancer is fundamental for prevention and the key is to find the marker which is expressed in high risk (cancerous and precancerous) but not in normal tissues.
COX-2 is an inducible enzyme expressed in response to a variety of physiological stimuli such as inflammation, wound healing and neoplasia.
These observations suggest that Non-steroidal anti-inflammatory drugs (NSAIDs) have a potent chemopreventive effect on colon cancer. NSAIDs have also been shown to exert anti-proliferative and pro-apoptotic effects on a variety of cell lines particularly colon cancer cell lines, suggesting a possible mechanism for their chemopreventive effect on colon cancer and COX is the molecular target of most of NSAIDs.
C-myc proto-oncogene as the cellular homologue to the transforming sequences of the avian myelocytomatosis retrovirus.